Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Trial Library
AddedFeb 17, 2024
UpdatedJun 18, 2026
Trial Library

Trial Library

Trial Library: Advancing health equity in cancer care through inclusive research and equitable clinical trial software.

HQ
San Francisco, CA, US
Founded
2022
Overview
Compare
Fundraising
Employees
Website

Trial Library, founded with a mission to advance health equity in cancer care, focuses on empowering patients and providers through inclusive research environments. The company offers software and services designed to accelerate equitable recruitment for cancer clinical trials, addressing disparities in discovery and access. By collaborating with community partners, Trial Library ensures diverse representation in oncology research, aiming to improve health outcomes for all.

Notable collaborators include various community partners and medical institutions committed to enhancing clinical trial inclusivity. Key achievements include the PROMISE Registry, a prostate cancer registry aimed at improving survival and treatment effectiveness through detailed genetic and outcome data. Trial Library's impact is evident in its commitment to transforming the standard of care in oncology by promoting equitable access to precision medicine and clinical trials.

Trial Library - Similar Companies

Clinical Platform logo

Clinical Platform

Leal Health logo

Leal Health

leal.health

Curebase logo

Curebase

curebase.com

On-Time Trials logo

On-Time Trials

ontimetrials.com

Power Life Science logo

Power Life Science

withpower.com

Leapcure logo

Leapcure

leapcure.com

Miracle logo

Miracle

miracleml.com

Triomics logo

Triomics

triomics.com

Paradigm logo

Paradigm

paradigm.inc

High Enroll logo

High Enroll

highenroll.org

Clinical.Ly logo

Clinical.Ly

clinical.ly

TrialSpark logo

TrialSpark

trialspark.com

Citruslabs logo

Citruslabs

citruslabs.com

SiteBridge Research logo

SiteBridge Research

Biogenesis Trials logo

Biogenesis Trials

mybiogenesis.com

Trial Library - Quick Facts

Who are Trial Library's competitors?

Companies similar to Trial Library include Clinical Platform, Leal Health, Curebase and On-Time Trials.

When was Trial Library founded?

Trial Library was founded in 2022.

Where is Trial Library's headquarters located?

Trial Library's headquarters is located in San Francisco, CA, US.

When was Trial Library's last funding round?

Trial Library's most recent funding round was for $5M (USD) in August 2022.

How much has Trial Library raised to-date?

As of Aug 18, 2022, Trial Library has raised a total of $5M (USD).

How many employees does Trial Library have?

Trial Library has 14 employees as of Feb 4, 2024.

Trial Library - Classification

Ownership
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Services
  • Software
Tags
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified